WO2004052914A8 - Compositions and methods for inhibiting malaria protease falcipain-2 - Google Patents
Compositions and methods for inhibiting malaria protease falcipain-2Info
- Publication number
- WO2004052914A8 WO2004052914A8 PCT/US2003/038835 US0338835W WO2004052914A8 WO 2004052914 A8 WO2004052914 A8 WO 2004052914A8 US 0338835 W US0338835 W US 0338835W WO 2004052914 A8 WO2004052914 A8 WO 2004052914A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- falcipain
- peptides
- compositions
- antibodies
- Prior art date
Links
- 108010017232 falcipain 2 Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000008102 Ankyrins Human genes 0.000 abstract 2
- 108010049777 Ankyrins Proteins 0.000 abstract 2
- 101710196266 Protein 4.1 Proteins 0.000 abstract 2
- 102100031952 Protein 4.1 Human genes 0.000 abstract 2
- 210000003743 erythrocyte Anatomy 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 210000003617 erythrocyte membrane Anatomy 0.000 abstract 1
- 230000008755 exit from host cell Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003298035A AU2003298035A1 (en) | 2002-12-06 | 2003-12-05 | Compositions and methods for inhibiting malaria protease falcipain-2 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43129402P | 2002-12-06 | 2002-12-06 | |
US60/431,294 | 2002-12-06 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004052914A2 WO2004052914A2 (en) | 2004-06-24 |
WO2004052914A8 true WO2004052914A8 (en) | 2004-10-14 |
WO2004052914A3 WO2004052914A3 (en) | 2004-12-29 |
Family
ID=32507704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/038835 WO2004052914A2 (en) | 2002-12-06 | 2003-12-05 | Compositions and methods for inhibiting malaria protease falcipain-2 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003298035A1 (en) |
WO (1) | WO2004052914A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017518514A (en) * | 2014-05-16 | 2017-07-06 | インターミューン, インコーポレイテッド | LPA-related protein and RNA expression |
CN110297095A (en) * | 2019-07-26 | 2019-10-01 | 四川农业大学 | A kind of screening technique of insect allergic protein |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225086B1 (en) * | 1997-05-21 | 2001-05-01 | Yale University | Polynucleotides encoding ankyrin proteins |
-
2003
- 2003-12-05 WO PCT/US2003/038835 patent/WO2004052914A2/en not_active Application Discontinuation
- 2003-12-05 AU AU2003298035A patent/AU2003298035A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003298035A8 (en) | 2004-06-30 |
WO2004052914A2 (en) | 2004-06-24 |
AU2003298035A1 (en) | 2004-06-30 |
WO2004052914A3 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003016475A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
EP1440981A3 (en) | Full-length human cdna | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2005016962A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004092199A3 (en) | Method for identifying modulators of g protein coupled receptor signaling | |
WO2004103304A3 (en) | Treatment of t-cell mediated diseases | |
WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
WO2005047511A3 (en) | Bacterial expression of protease inhibitors and variants thereof | |
WO2002011756A3 (en) | Anti-plasmodium compositions and methods of use | |
TW200715985A (en) | Systems and methods for separating proteins from connective tissue | |
WO2005030793A3 (en) | Antibodies which bind human cxcr3 | |
WO2002040668A3 (en) | Proteins and dna sequences underlying these proteins used for treating inflammations | |
WO2006017355A3 (en) | Improved aprotinin variants | |
WO2005000862A3 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
WO2004052914A8 (en) | Compositions and methods for inhibiting malaria protease falcipain-2 | |
WO2003020887A3 (en) | Gene identification | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
WO2005002509A3 (en) | Dna vectors | |
WO2005060667A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
WO2002053586A3 (en) | Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them | |
WO2004004649A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2004053117A3 (en) | Serine protease | |
WO2003073980A3 (en) | Recombinant protein c variants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 26/2004 UNDER (72, 75) REPLACE "CHISHTI, ATHAR, H. [US/US] DEPT. OF PHARMACOLOGY, UNIVERSITY OF ILLINOIS COOLLEGE OF MEDICINE, 900 A. ASHLAND AVENUE, CHICAGO, IL 60607 (US). " BY "CHISHTI, ATHAR, H. [US/US] DEPT. OF PHARMACOLOGY, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE, 900 A. ASHLAND AVENUE, CHICAGO, IL 60607 (US). " |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 26/2004 UNDER (72, 75) THE ADDRESS OF "CHISHTI, ATHAR, H." SHOULD READ "DEPT. OF PHARMACOLOGY, UNIVERSITY OF ILLINOIS COLLEGE OF MEDECINE, 900 S. ASHLAND AVENUE, CHICAGO, IL 60607 (US)" |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |